Abbott touted its Absorb fully-resorbable coronary scaffold but physicians never saw clear clinical benefit over the standard of treatment leading the company to halt sales of the expensive device just over a year after FDA approval.
Amaranth Medical, a medical device company with roots in California and Singapore, has raised $20 million for a series B round. The money will support continued development of the company’s bioresorbable scaffold (a dissolving stent) technology and the CE Mark approval process. General Manager and Chief Technical Officer Kamal Ramzipoor compared the stent to a cast. […]
SharedClarity has created an alliance of long-time healthcare frenemies (payers and providers) to test effectiveness of heart and orthopedic medical devices with the aim of lowering costs, reducing readmissions, allowing members to negotiate device pricing and getting patients effective implantable devices. For the study, United Healthcare will join forces with Baylor Healthcare System in Dallas, Dignity Health in […]
Cook Medical has received FDA approval for the first drug-eluting stent to treat peripheral artery disease in the U.S. The Zilver PTX Drug-Eluting Peripheral Stent is a self-expanding metal stent coated with the drug paclitaxel to help prevent recurring narrowing of the artery. Drug-eluting stents are currently approved for use in coronary arteries in heart […]
